EP. 1: Testing for islet autoantibodies to monitor type 1 diabetes development
Brittany Bruggeman, MD, highlighted the ability to predict type 1 diabetes months to years in advance through islet autoantibodies, and how the pediatrician can play a role.
EP. 2: Communicating availability of continuous glucose monitors for type 1 diabetes patients
Brittany Bruggeman, MD, emphasizes that many patients with type 1 diabetes are unaware of the availability of advanced technologies like CGMs and automated insulin delivery systems.
EP. 3: New glucagon formulations simplify emergency treatment for T1D patients
Brittany Bruggeman, MD, highlights the importance of newer, easier-to-use glucagon formulations in treating severe hypoglycemia in patients with type 1 diabetes.
